Literature DB >> 22356219

Heterogeneity of chronic pain.

Renato Vellucci1.   

Abstract

Chronic pain is a widespread public health issue that has many effects on physical, emotional and cognitive functions. An estimated 10-55% of all adults are thought to have chronic pain. Chronic pain is a multifactorial condition, caused by the complex interplay of nociceptive, neuropathic or mixed pathogenic mechanisms. Chronic pain is associated with specific and non-specific medical conditions such as cancer, HIV/AIDS, rheumatoid arthritis, fibromyalgia, osteoarthritis, low back pain or spinal stenosis and is broadly categorized as cancer pain and non-cancer pain. Evaluation of chronic pain requires a clear understanding of the nature of the pain and its underlying pathophysiology. Adequate assessment of pain, using validated tools, is an essential prerequisite of successful pain management. Unidimensional scales are useful for the measurement of pain intensity, while multidimensional scales measure both pain intensity and the extent to which pain interferes with life activity and emotional functioning. Patients should be reassessed and followed up in order to monitor progress and measure improvements in pain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356219     DOI: 10.2165/11630030-000000000-00000

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  27 in total

Review 1.  Can quantitative sensory testing move us closer to mechanism-based pain management?

Authors:  Yenisel Cruz-Almeida; Roger B Fillingim
Journal:  Pain Med       Date:  2013-09-06       Impact factor: 3.750

Review 2.  Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids.

Authors:  Renato Vellucci; Consalvo Mattia; Ludovica Celidonio; Rocco Domenico Mediati
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

3.  sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain.

Authors:  Dan Kaufmann; Peter J West; Misty D Smith; Boris Yagen; Meir Bialer; Marshall Devor; H Steve White; K C Brennan
Journal:  Pharmacol Res       Date:  2016-11-24       Impact factor: 7.658

4.  [Cerebral metabolic changes and chronic back pain: Study taking into consideration clinical and psychological parameters].

Authors:  L Janetzki; A Gussew; R Malessa; U Habenicht; J R Reichenbach; B Strauß; C Borys
Journal:  Schmerz       Date:  2016-04       Impact factor: 1.107

5.  Upregulation of neuregulin-1 reverses signs of neuropathic pain in rats.

Authors:  Guojun Wang; Dawei Dai; Xin Chen; Lei Yuan; Aijun Zhang; Youming Lu; Pengqi Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 6.  Myofascial low back pain treatment.

Authors:  Deepak Sharan; Joshua Samuel Rajkumar; Mathankumar Mohandoss; Rameshkumar Ranganathan
Journal:  Curr Pain Headache Rep       Date:  2014-09

7.  Pain thresholds following maximal endurance exercise.

Authors:  Steffen Krüger; Dominik Khayat; Meike Hoffmeister; Thomas Hilberg
Journal:  Eur J Appl Physiol       Date:  2015-12-23       Impact factor: 3.078

Review 8.  Understanding osteoporotic pain and its pharmacological treatment.

Authors:  R Vellucci; R Terenzi; J A Kanis; H G Kress; R D Mediati; J-Y Reginster; R Rizzoli; M L Brandi
Journal:  Osteoporos Int       Date:  2018-04-04       Impact factor: 4.507

9.  Comparative transcriptome profiling of the human and mouse dorsal root ganglia: an RNA-seq-based resource for pain and sensory neuroscience research.

Authors:  Pradipta Ray; Andrew Torck; Lilyana Quigley; Andi Wangzhou; Matthew Neiman; Chandranshu Rao; Tiffany Lam; Ji-Young Kim; Tae Hoon Kim; Michael Q Zhang; Gregory Dussor; Theodore J Price
Journal:  Pain       Date:  2018-07       Impact factor: 7.926

Review 10.  Mixing omics: combining genetics and metabolomics to study rheumatic diseases.

Authors:  Cristina Menni; Jonas Zierer; Ana M Valdes; Tim D Spector
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.